AI assistant
Novonesis AS — Director's Dealing 2009
Nov 25, 2009
3377_rpt_2009-11-25_02e6fca2-2123-4de5-9483-ef6f1fea5618.pdf
Director's Dealing
Open in viewerOpens in your device viewer
TRADING BY MANAGEMENT IN NOVOZYMES A/S B SHARES
November 25, 2009
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
| Name | Relation/ Category of close relation |
Trading date | Character of the transaction |
No. of shares traded Buy (+) / Sell (-) |
Market value of shares traded (DKK) |
|---|---|---|---|---|---|
| Steen Riisgaard | President & CEO | 24/11 2009 | Share options | + 5,559 - 5,559 |
883,881 2,795,677 |
Contact persons:
| Press and media: | Investor relations: | ||
|---|---|---|---|
| Annegrethe M. Jakobsen (Europe) | Tobias Bjørklund | ||
| Tel. (direct): +45 4446 3050 | Tel. (direct): +45 4446 8682 | ||
| Tel. (mobile): +45 3077 3050 | Tel. (mobile): +45 3077 8682 | ||
| Paige Donnelly (USA) | Thomas Bomhoff (USA) | ||
| Tel. (direct): +1 919 494 3209 | Tel. (direct): +1 919 494 3483 |
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Company announcement no. 14, 2009 Page 1 of 1 Novozymes A/S Investor Relations
Tel. (mobile): +1 919 218 4501
Krogshøjvej 36 2880 Bagsværd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 9999
Tel. (mobile): +1 919 649 2565
Internet: www.novozymes.com CVR number: 10 00 71 27